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Introduction
Metabolic syndrome (MetS) is associated with cardiovas-
cular mortality and increased risk of type 2 diabetes.
Methods
We examine the prevalence of MetS in a cohort of Cauca-
sian women with previous gestational diabetes (GDM)
(n=116), and those with normal glucose tolerance (NGT)
during pregnancy (n=51). Fasting glucose alone (known
DM/pre-diabetes post-partum patients) or 75g OGTT
(other patients), lipid profile, insulin and c-peptide were




Metabolic syndrome and insulin resistance are signifi-
cantly more prevalent in Caucasian patients with GDM
progressing to post-partum DM/pre-diabetes than those
who do not (p<0.01), suggesting a need to target lifestyle
changes in the early post-partum period to help prevent
progression to T2DM.
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Table 1
Number with MetS (ATPIII criteria) (%) Mean HOMA-2IR (+/- SD) Number with HOMA-2IR>1.7 (%)
DM/pre-diabetes post GDM (n=33) 12 (36%) 1.21(+/-0.77) 18 (55%)
NGT post GDM (n= 83) 11 (13%) 1.93(+/-1.4) 18 (22%)
No history GDM (n=52) 3 (6%) 1.02(+/-0.85) 6 (13%)
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